Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 552 Neoplasms 502 Carcinoma, Non-Small-Cell Lung 419 Prostatic Neoplasms 326 Colorectal Neoplasms 310 Lung Neoplasms 280 Neoplasm Metastasis 233 Leukemia, Myeloid, Acute 222 Ovarian Neoplasms 205 Pancreatic Neoplasms 195 Multiple Myeloma 186 Recurrence 141 Squamous Cell Carcinoma of Head and Neck 140 Brain Neoplasms 139 Stomach Neoplasms 138 Melanoma 132 Carcinoma, Hepatocellular 130 Endometrial Neoplasms 127 Glioblastoma 124 Triple Negative Breast Neoplasms 116 Precursor Cell Lymphoblastic Leukemia-Lymphoma 115 Hematologic Neoplasms 102 Head and Neck Neoplasms 100 Urinary Bladder Neoplasms 98 Carcinoma, Renal Cell 98 Lymphoma 97 Glioma 94 Sarcoma 93 Esophageal Neoplasms 90 Uterine Cervical Neoplasms 88

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HER2 Negative Breast Cancer × 90 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡